Prognostic and biologic significance of DNMT3B expression in older patients with cytogenetically normal primary acute myeloid leukemia-Reference-Cited by-同舟云学术

Prognostic and biologic significance of DNMT3B expression in older patients with cytogenetically normal primary acute myeloid leukemia

Published:2014-09-10 Issue:3 Volume:29 Page:567-575
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Niederwieser C,Kohlschmidt J,Volinia S,Whitman S P,Metzeler K H,Eisfeld A-K,Maharry K,Yan P,Frankhouser D,Becker H,Schwind S,Carroll A J,Nicolet D,Mendler J H,Curfman J P,Wu Y-Z,Baer M R,Powell B L,Kolitz J E,Moore J O,Carter T H,Bundschuh R,Larson R A,Stone R M,Mrózek K,Marcucci G,Bloomfield C D

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2014267.pdf

Reference60 articles.

1. Mrózek K, Heerema NA, Bloomfield CD . Cytogenetics in acute leukemia. Blood Rev 2004; 18: 115–136.

2. Mrózek K, Marcucci G, Paschka P, Whitman SP, Bloomfield CD . Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification?. Blood 2007; 109: 431–448.

3. Walker A, Marcucci G . Molecular prognostic factors in cytogenetically normal acute myeloid leukemia. Expert Rev Hematol 2012; 5: 547–558.

4. Whitman SP, Maharry K, Radmacher MD, Becker H, Mrózek K, Margeson D et al. FLT3 internal tandem duplication associates with adverse outcome and gene- and microRNA-expression signatures in patients 60 years of age or older with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study. Blood 2010; 116: 3622–3626.

5. Becker H, Marcucci G, Maharry K, Radmacher MD, Mrózek K, Margeson D et al. Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and associated gene- and microRNA-expression signatures: a Cancer and Leukemia Group B study. J Clin Oncol 2010; 28: 596–604.

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A telomere-related gene risk model for predicting prognosis and treatment response in acute myeloid leukemia;Heliyon;2024-06

2. Research Trends on the Impact of DNA Methylation on Acute Myeloid Leukemia;Advances in Clinical Medicine;2024

3. A novel scoring system for the quantitative prediction of prognosis in acute myeloid leukemia;Frontiers in Oncology;2023-03-30

4. Thymoquinone, piperine, and sorafenib combinations attenuate liver and breast cancers progression: epigenetic and molecular docking approaches;BMC Complementary Medicine and Therapies;2023-03-04

5. Epigenetic regulation in hematopoiesis and its implications in the targeted therapy of hematologic malignancies;Signal Transduction and Targeted Therapy;2023-02-17